Alimera Sciences to Participate in Upcoming January 2022 Investor Conferences
Alimera Sciences (Nasdaq: ALIM) has announced that Rick Eiswirth, President and CEO, will participate in two significant investor conferences in January 2022. He will present at the H.C. Wainwright BioConnect 2022 Virtual Conference, with a pre-recorded session available from January 10 to January 13, 2022. Additionally, he will host one-on-one meetings at the Bio One-on-One Partnering @ JPM event, scheduled for January 10-14, 2022. Alimera focuses on enhancing retinal health and vision longevity for patients and partners.
- None.
- None.
ATLANTA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will participate in two investor conference events in January.
Mr. Eiswirth will be presenting at the H.C. Wainwright BioConnect 2022 Virtual Conference. The pre-recorded presentation will be accessible to H.C. Wainwright registered attendees beginning at 7:00 AM ET on Monday, January 10, 2022 - January 13, 2022.
Additionally, Mr. Eiswirth will be hosting one-on-one meetings with registered attendees at Bio One-on-One Partnering @ JPM, January 10, 2022 – January 14, 2022.
About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
What investor conferences is Alimera Sciences attending in January 2022?
When will Rick Eiswirth's presentation be available for the H.C. Wainwright conference?
What is the purpose of Alimera Sciences' participation in these events?
What is Alimera Sciences' mission?